Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Category: CD as API

May 12, 2022 CD as API / Pharma applications

Cothreading of Unmodified and Monoazidated β-Mixed cyclodextrins in polyrotaxanes for Niemann Pick disease

To establish a method for the orthogonal chemical functionalization of β-cyclodextrin (β-CD)-based polyrotaxane (PRX), unmodified and monoazidated β-CDs (N3-β-CDs) were

Continue reading

May 4, 2022 CD as API / CD derivatives / Drug delivery / Pharma applications

Implementation of water-soluble cyclodextrin-based polymers in biomedical applications: how far are we?

Cyclodextrin-based polymers can be prepared starting from the naturally occurring monomers following green and low-cost procedures. They can be selectively

Continue reading

March 24, 2022 CD as API / CD derivatives / Pharma applications / Supramolecular systems

Antidote-like effect of SBECD of plant neurotoxin veratridine on neuro-2a cell viability

A research team consisting of scientists located in Spain and Denmark have successfully proven that the formation of inclusion complexes

Continue reading

March 22, 2022 CD as API / Life sciences / Pharma applications

Methyl BCD against malaria?

The researchers of College of Medicine (Pennsylvania) and Iowa University have published on ‘Dramatic Consequences of Reducing Erythrocyte Membrane Cholesterol

Continue reading

March 18, 2022 CD as API / Events / Pharma applications

International Conference on Orphan Drugs and Rare Diseases

The International conference on Orphan Drugs and Rare Diseases will be taking place during August 8-10, 2022 as a hybrid

Continue reading

March 14, 2022 CD as API / Pharma applications

Cyclo Therapeutics on Phase 3 Clinical Development Program for Trappsol® Cyclo™ in Niemann-Pick Disease Type C

Businesswire published: Cyclo Therapeutics Announces Formation of Global Steering Committee Comprised of Leading Experts to Advise on the Global Phase

Continue reading

March 8, 2022 CD as API / Pharma applications

Nature News on Covid drugs: overview and new trends

Over the past two years, the ACTIV programme, run by the US National Institutes of Health (NIH), has included more

Continue reading

February 23, 2022 CD as API / Pharma applications

HPBCD for Treatment of Parkinson Disease

The recent work of Jarazo et al. demonstrates that HP-β-CD ameliorates the dopaminergic neuronal loss phenotype, confirming the therapeutic potential

Continue reading

February 9, 2022 CD as API / Drug delivery / Pharma applications

Versatile Nasal Application of Cyclodextrins: Excipients and/or Actives?

The use of CDs in nasal formulations allowed obtaining versatile drug delivery systems intended for local and systemic effects, as

Continue reading

February 2, 2022 CD as API / Pharma applications

Sugammadex in Colorectal and da Vinci Surgery

Traditionally, reversal of neuromuscular blocking agents following the completion of surgery was achieved with cholinesterase inhibitors. Recently, sugammadex has been

Continue reading

Posts navigation

1 2 3 … 18 Next Posts»

Recent Posts

  • Update: FDA approves HPBCD-enabled tecovirimat against pox virus
  • Life cycle of Tecovirimat authorized to treat human monkeypox infection in EU has been extended by reformulation with HPBCD by the originator Siga Technologies.
  • pH-Responsive templates modulate the dynamic enzymatic synthesis of cyclodextrins
  • Hadakara medicinal deodorant body soap
  • Statistics on CD-containing cosmetic products in the US

Tags

antiviral Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease RAMEB remdesivir SBECD Special issue Sugammadex Synthesis Trappsol wastewater treatment

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (13)
  • Analysis (25)
  • CD as API (174)
  • CD derivatives (223)
  • Cosmetics and toilettry (17)
  • Drug delivery (340)
  • E-ducation (49)
  • Environmental (61)
  • Events (142)
  • Food (97)
  • Gene delivery (6)
  • In Hungarian (4)
  • Life sciences (8)
  • Non-pharma applications (158)
  • Other industrial use (49)
  • Pharma applications (575)
  • Supramolecular systems (18)
  • Uncategorized (32)

Top Posts

  • pH-Responsive templates modulate the dynamic enzymatic synthesis of cyclodextrins
  • Update: FDA approves HPBCD-enabled tecovirimat against pox virus
  • Life cycle of Tecovirimat authorized to treat human monkeypox infection in EU has been extended by reformulation with HPBCD by the originator Siga Technologies.
  • 10th Asian Cyclodextrin Conference (ACC2019)
  • Practical Considerations about the Cyclodextrin Solubilities – A Quickstart Guide for Newbies
  • Pilocarpine eye drops (Vuity)
  • Cholesterol/β-cyclodextrin complexation revisited by combined experimental and computational approaches
  • Nasal delivery with beta-cyclodextrin is approved; a short story of Baqsimi
  • International Conference on Bioinspiration and Biobased​ Materials
  • Cyclodextrins in soft drinks

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 417 other subscribers

 

Loading Comments...